Ray Dalio Trans Medics Group, Inc. Transaction History
Bridgewater Associates, LP
- $17.3 Billion
- Q3 2024
A detailed history of Ray Dalio (Bridgewater Associates, LP) transactions in Trans Medics Group, Inc. stock. As of the latest transaction made, Bridgewater Associates, LP holds 4,872 shares of TMDX stock, worth $300,602. This represents 0.0% of its overall portfolio holdings.
Number of Shares
4,872
Previous 22,196
78.05%
Holding current value
$300,602
Previous $3.34 Million
77.15%
% of portfolio
0.0%
Previous 0.02%
Shares
14 transactions
Others Institutions Holding TMDX
# of Institutions
397Shares Held
31.7MCall Options Held
466KPut Options Held
286K-
Vanguard Group Inc Valley Forge, PA3.6MShares$222 Million0.01% of portfolio
-
Black Rock Inc. New York, NY2.65MShares$163 Million0.01% of portfolio
-
Driehaus Capital Management LLC Chicago, IL1.44MShares$89 Million2.22% of portfolio
-
State Street Corp Boston, MA1.27MShares$78.6 Million0.01% of portfolio
-
Invesco Ltd. Atlanta, GA1.09MShares$67.5 Million0.03% of portfolio
About TransMedics Group, Inc.
- Ticker TMDX
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 31,831,400
- Market Cap $1.96B
- Description
- TransMedics Group, Inc., a commercial-stage medical technology company, engages in transforming organ transplant therapy for end-stage organ failure patients in the United States and internationally. The company offers Organ Care System (OCS), a portable organ perfusion, optimization, and monitoring system that utilizes its proprietary and custo...